Requests similar to 'Discontinuation of Phenelzine Sulphare'
Shortage of Phenelzine sulphate
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs
Please find attached a letter and related documents related to your request for information about phenelzine supply.
Kind regards
Simon E...
Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Awaiting classification.
Good morning Belinda
Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Services Adv...
Has Pharmac Ever Funded A Sativex Prescritpion?
Response by Pharmaceutical Management Agency to Gregory Soar on .
Successful.
Dear Mr Soar,
Please find attached letter regarding your OIA request on 26 June 2015.
Kind regards
Alexis Poppelbaum
PHARMAC
24 July 20...
Dispensed drugs, media and events information request
Response by Pharmaceutical Management Agency to Joe Heihei on .
Awaiting classification.
Dear Joe
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
25 May 2018
Dear Joe
REQUEST FO...
Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit
Follow up sent to Pharmaceutical Management Agency by Micky Turner on .
Successful.
Hi Melody,
Thanks for providing the information!
Here is a summary of the details:
Remdesivir is a failed Ebola drug. It was designed to treat E...
Management of Stelazine (trifluoperazine) supply
Response by Pharmaceutical Management Agency to WGRH on .
Information not held.
Dear Dr Harrison,
PHARMAC is extending the response date for your request, please see letter attached.
Please let me know if you have any questions o...
Information regarding medicinal cannabis prescriptions
Response by Pharmaceutical Management Agency to Mr McDonald on .
Information not held.
Kia ora Mr McDonald,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pāt...
Management of Dexamfetamine supply
Response by Pharmaceutical Management Agency to Anita Easton on .
Partially successful.
Dear Anita
Please find attached PHARMAC’s response to your recent OIA request.
Kind regards
Victoria London
PHARMAC
15 Feb...
Which thyroid medications and bio-identical T4, T3 equivalents meet criteria for government funding
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Successful.
Good morning Ms Hodson,
Please find attached PHARMAC’s response to your OIA request.
Kind regards
Alexis Poppelbaum
PHARMAC
28 August 2...
Shortage of prescribed medication Concerta
Response by Pharmaceutical Management Agency to gerald on .
Awaiting classification.
Kia ora Gerald
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
__...
Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find a response for your request for information attached with this email.
Ngā mihi
Simon
Simon Mitchell | Senior Policy Adviso...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam
Please find a response to your request attached with this email.
Ngā mihi
Melody Willis ([1]she/her) | Government Se...
Trikafta Funding Announcement
Response by Pharmaceutical Management Agency to Phillip Hart on .
Partially successful.
Tçnâ koe Phillip
Further to our previous communications, we have now published
[1]information about our communications approach for the Trikafta...
Cancer drugs v other drugs
Response by Pharmaceutical Management Agency to Brendon Mills on .
Successful.
Kia ora Brendon
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
_...
Decision not to provide information to Today FM or Mediaworks
Response by Pharmaceutical Management Agency to New Zealand Council for Civil Liberties on .
Refused.
Tēnā koe
Further to our previous communications, we have now published
[1]information about our communications approach for the Trikafta
consul...
Estimating the number of people prescribed PrEP
Response by Pharmaceutical Management Agency to Bianca Sepulveda on .
Successful.
Kia ora Bianca
Please find attached a response to your recent request for information.
Ngā mihi
Melody Willis ([1]she/her) | Gove...
OFI patient numbers & Costs
Response by Pharmaceutical Management Agency to Jennifer Jiayi on .
Partially successful.
Kia ora Jennifer
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data
Response by Pharmaceutical Management Agency to J Bruning on .
Awaiting classification.
Kia ora J
Please find attached a response to your request for official information.
Ngâ mihi,
Government Services | Pharmac
________________________...
Approval of PHARMAC funded thyroid medications
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Good afternoon Belinda.
Please find attached our response to your request for PTAC minutes and the Endocrinology Subcommittee minutes that recommended...
Why have you restricted Ivermectin?
Response by Pharmaceutical Management Agency to Annie Weston on .
Successful.
Mōrena Annie
Please find a response to your request about ivermectin attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Servic...
Information regarding Dexcom CGMS and Libre FGMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Further to our previous email to you on Friday 19 March 2021, please find
attached the final response to your request for inform...
Cost of PreP since funding began in 2018
Response by Pharmaceutical Management Agency to Elliot Ikilei on .
Successful.
Kia ora Elliot
Please find attached a response to your request for information received
by PHARMAC on 6 January 2021.
Please feel free to...
Conflicts of interest at NZ Immunisation Advisory Service
Response by Ministry of Health to Erika Whittome on .
Long overdue.
Kia ora Erika
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
___...
School of Medicine OIA request for Formal training on CB1, CB2 receptors and effects.
Response by University of Auckland to Shane Le Brun on .
Successful.
[1]Image
This message is from the University of Auckland.
Subject [studentinfo] Official Information Act request - School of
Medicine OIA request...
